Nyxoah (NASDAQ:NYXH – Get Free Report) and Atrion (NASDAQ:ATRI – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, risk, institutional ownership and dividends. Institutional and Insider Ownership 66.2% of Atrion shares are owned […]
A number of research firms have changed their ratings and price targets for Nyxoah (NASDAQ: NYXH): 3/20/2024 – Nyxoah had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock, up previously from $18.00. 3/20/2024 – Nyxoah had its price target raised by analysts at Stifel […]
HC Wainwright reiterated their buy rating on shares of Nyxoah (NASDAQ:NYXH – Free Report) in a report released on Wednesday, Benzinga reports. The brokerage currently has a $22.00 price target on the stock, up from their prior price target of $18.00. Several other brokerages have also recently commented on NYXH. Cantor Fitzgerald raised their target […]
Nyxoah (NASDAQ:NYXH – Get Free Report) and Monogram Orthopaedics (NASDAQ:MGRM – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, profitability and risk. Valuation and Earnings This table compares Nyxoah and Monogram […]
Nyxoah (NASDAQ:NYXH – Get Free Report) and Monogram Orthopaedics (NASDAQ:MGRM – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, institutional ownership, earnings, risk and profitability. Institutional and Insider Ownership 0.3% of Monogram Orthopaedics shares […]